1-METHYL-4-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)PIPERIDINE, 95.0%, 10g

N-Phenylbenzylamine>98.0%(GC)500g

3-Methyl-5-nitro-1H-indole, 98%, 1g

3-Oxa-9-azabicyclo[3.3.1]nonan-7-one hydrochloride, 95.0%, 5g

(S)-2,3-Dihydro-1H-inden-1-ol, 98%, 5g

Colonna capillare per GC ROTI®Cap-1701, 25 m, 0,25 mm, 0,25 µm, 1 Pezzo(i)

3-(4-Fluorophenyl)-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 250mg

3,4-Methylenedioxyphenylacetic Acid>98.0%(GC)(T)25g

5-(3-(2,5-Dichloro-4,6-dimethylpyridin-3-yl)-1,2,4-oxadiazol-5-yl)-3-nitrobenzene-1,2-diol, 98%, 100mg

4-(Chloro-difluoro-methyl)-benzonitrile, 1g

Methyl 2-((tert-butoxycarbonyl)amino)isonicotinate, 95.0%, 1g

5-Methoxypyrazine-2-carboxylic acid, 95.0%, 5g

D-luciferina, minimo 99%, per biochimica, 50 mg, confezione in vetro